POSC65 Cost-Benefit Analysis of Ready-to-Administer Noradrenaline for Hypotensive Emergency on Intensive Care
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.470
https://www.valueinhealthjournal.com/article/S1098-3015(21)02265-8/fulltext
Title :
POSC65 Cost-Benefit Analysis of Ready-to-Administer Noradrenaline for Hypotensive Emergency on Intensive Care
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02265-8&doi=10.1016/j.jval.2021.11.470
First page :
Section Title :
Open access? :
No
Section Order :
11243